A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19)
View ORCID ProfileCheng-Pin Chen, Yi-Chun Lin, Tsung-Chia Chen, Ting-Yu Tseng, Hon-Lai Wong, Cheng-Yu Kuo, Wu-Pu Lin, Sz-Rung Huang, Wei-Yao Wang, Jia-Hung Liao, Chung-Shin Liao, Yuan-Pin Hung, Tse-Hung Lin, Tz-Yan Chang, View ORCID ProfileChin-Fu Hsiao, View ORCID ProfileYi-Wen Huang, View ORCID ProfileWei-Sheng Chung, View ORCID ProfileChien-Yu Cheng, View ORCID ProfileShu-Hsing Cheng on behalf of the Taiwan HCQ Study Group
doi: https://doi.org/10.1101/2020.07.08.20148841
Cheng-Pin Chen
1Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
2Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
Yi-Chun Lin
1Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
3Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan
Tsung-Chia Chen
4Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan
Ting-Yu Tseng
4Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan
Hon-Lai Wong
5Department of Internal Medicine, Keelung Hospital, Ministry of Health and Welfare, Keelung City, Taiwan
Cheng-Yu Kuo
6Department of Internal Medicine, Pingtung Hospital, Ministry of Health and Welfare, Pingtung, Taiwan
Wu-Pu Lin
7Department of Internal Medicine, Taipei Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan
Sz-Rung Huang
8Department of Internal Medicine, Miaoli General Hospital, Ministry of Health and Welfare, Miaoli, Taiwan
Wei-Yao Wang
9Department of Internal Medicine, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan
Jia-Hung Liao
10Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, Nantou, Taiwan
Chung-Shin Liao
11Department of Internal Medicine, Chia Yi Hospital, Ministry of Health and Welfare, Chiayi, Taiwan
Yuan-Pin Hung
12Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan City, Taiwan
Tse-Hung Lin
13Department of Internal Medicine, Chang Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan
Tz-Yan Chang
13Department of Internal Medicine, Chang Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan
Chin-Fu Hsiao
14Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan
Yi-Wen Huang
13Department of Internal Medicine, Chang Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan
15Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
Wei-Sheng Chung
4Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan
16Department of Health Service Administration, China Medical University, Taichung, Taiwan
17Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, Taiwan
Chien-Yu Cheng
1Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
18School of Public Health, National Yang-Ming University, Taipei, Taiwan
Shu-Hsing Cheng
1Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
19School of Public Health, Taipei Medical University, Taipei, Taiwan
Posted July 10, 2020.
A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19)
Cheng-Pin Chen, Yi-Chun Lin, Tsung-Chia Chen, Ting-Yu Tseng, Hon-Lai Wong, Cheng-Yu Kuo, Wu-Pu Lin, Sz-Rung Huang, Wei-Yao Wang, Jia-Hung Liao, Chung-Shin Liao, Yuan-Pin Hung, Tse-Hung Lin, Tz-Yan Chang, Chin-Fu Hsiao, Yi-Wen Huang, Wei-Sheng Chung, Chien-Yu Cheng, Shu-Hsing Cheng
medRxiv 2020.07.08.20148841; doi: https://doi.org/10.1101/2020.07.08.20148841
A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19)
Cheng-Pin Chen, Yi-Chun Lin, Tsung-Chia Chen, Ting-Yu Tseng, Hon-Lai Wong, Cheng-Yu Kuo, Wu-Pu Lin, Sz-Rung Huang, Wei-Yao Wang, Jia-Hung Liao, Chung-Shin Liao, Yuan-Pin Hung, Tse-Hung Lin, Tz-Yan Chang, Chin-Fu Hsiao, Yi-Wen Huang, Wei-Sheng Chung, Chien-Yu Cheng, Shu-Hsing Cheng
medRxiv 2020.07.08.20148841; doi: https://doi.org/10.1101/2020.07.08.20148841
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12630)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (411)
- Health Economics (717)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2230)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)